PUBLICATIONS


Publications from UT Austin (>2004):


Peer-reviewed journal articles (published and awaiting publication):

  1. Tu C, Das S, Baker AB, Zoldan J, Suggs LJ. Nanoscale Strategies-Treatment for Peripheral Vascular Disease and Critical Limb Ischemia. Manuscript In press to ACS Nano, 2015.

  2. Geuss LR, Ramamurthy D, Allen A and Suggs LJ. Maintenance of HL-1 cardiomyocyte functional activity in PEGylated fibrin gels. Biotechnology and Bioengineering, 2015, DOI: 10.1002/bit.25553.

  3. Stowers RS, Allen SC, Suggs LJ. Dynamic Photo-Tuning of 3D Hydrogel Stiffness. Proceedings of the National Academy of Sciences, 2015, 112(7): 1953-1958. doi: 10.1073/pnas.1421897112

  4. Chung E, Rytlewski JA, Merchant AG, Dhada KS, Lewis EW, Suggs LJ. Fibrin-based 3D matrices induce angiogenic behavior of adipose-derived stem cells for vascular tissue engineering. Acta Biomater., 2015, 17(15): 78-88.

  5. Hammers D, Rybalko V, Merscham-Banda M, Hsieh PL, Suggs LJ, and Farrar RP. Anti-inflammatory macrophages improve skeletal muscle recovery from ischemia/reperfusion. Journal of Applied Physiology, 2015, DOI: 10.1152/japplphysiol.00313.2014.

  6. Rytlewski JA, Aldon MA, Lewis EW, Suggs LJ. Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs. Microvascular Research, 2015, 99: 26-35.

  7. Nam SY, Chung E, Suggs LJ, Emelianov SY. Combined Ultrasound and Photoacoustic Imaging to Noninvasively Assess Burn Injury and Selectively Monitor a Regenerative Tissue-Engineered Construct. Tissue Engineering C: Methods, 2014, doi:10.1089/ten.tec.2014.0306.

  8. Ricles LM, Nam SY, Trevino EA, Emelianov SY, Suggs LJ. A dual gold nanoparticle system for mesenchymal stem cell tracking. Journal of Materials Chemistry B, 2014, 2: 8220-8230.

  9. Geuss LR and Suggs LJ. Paramagnetic beads and magnetically mediated strain enhance cardiomyogenesis in mouse embryoid bodies. PLoS ONE, 2014, DOI: 10.1371/journal.pone.0113982.

  10. Nam SY, Ricles LM, Suggs LJ, Emelianov SY. Imaging strategies for tissue engineering applications. Tissue Engineering Part B, 2015, 21(1): 88-102. doi:10.1089/ten.teb.2014.0180.

  11. Eckes KM*, Mu X*, Ruehle MA, Ren P, and Suggs LJ. Beta-sheets Not Required: Combined Experimental and Computational Studies of Self-Assembly and Gelation of the Ester-Containing Analogue of an Fmoc-Dipeptide Hydrogelator. Langmuir, 2014, 30(18): 5287-5296. *Authors contributed equally to this work.

  12. Nguyen MM, Eckes KM, Suggs LJ. Controlling the Self-Assembly of Fmoc-Depsipeptides into Fibers or Hydrogels via Sequence and Ionic Character. Soft Matter, 2014. 10(15): 2693-2014.

  13. Geuss LR and Suggs LJ. Making Cardiomyocytes: How mechanical stimulation can influence differentiation of pluripotent stem cells. Biotechnology Progress, 2013, Aug 16. doi: 10.1002/btpr.1794.

  14. Nagao RJ, Ouyang Y, Keller R, Lee C, Suggs LJ, Schmidt CE. Preservation of capillary-beds in rat lung tissue using optimized chemical decellularization. Journal of Materials Chemistry B, 2013, 1: 4801-4808.

  15. Zamora DO, Natesan S, Becerra S, Wrice N, Chung E, Suggs LJ and Christy RJ. Enhanced wound vascularization using a dsASCs seeded FPEG scaffold. Angiogenesis, 2013, doi: 10.1007/s10456-013-9352-y.

  16. Stowers RS*, Drinnan CT*, Chung E, Suggs LJ. Mesenchymal Stem Cell Response to TGF-beta1 in Both 2D and 3D Environments. Biomaterials Science, 2013, 1: 860-869. doi: 10.1039/C3BM60057B. *Authors contributed equally to this work.

  17. Nguyen MM, Ong N, Suggs LJ. A general solid phase method for the synthesis of depsipeptides. Org Biomol Chem. 2013 Feb 21; 11(7):1167-70.

  18. Chung E, Nam SY, Ricles LM, Emelianov SY, and Suggs LJ. Evaluation of Gold Nanotracers to Track Adipose-Derived Stem Cells in a PEGylated Fibrin Gel for Dermal Tissue Engineering Applications. Int J Nanomed, 2013, 8: 325-336.

  19. Nam SY, Ricles LM, Suggs LJ, and Emelianov SY. Nonlinear photoacoustic signal increase of endocytosed gold nanoparticles. Optics Letters, 2012, 37(22): 4708-4710.

  20. Mu X*, Eckes KM*, Nguyen MM, Suggs LJ and Ren P. Experimental and Computational Studies Reveal An Alternative Supramolecular Structure for Fmoc-dipeptide Self-Assembly. Biomacromolecules, 2012, 13(11): 3562-3571. *Authors contributed equally to this work.

  21. Chung E*, Ricles LM*, Stowers RS, Nam SY, Emelianov SY, and Suggs LJ. Multifunctional Nanoscale Strategies for Enhancing and Monitoring Blood Vessel Regeneration. Submitted to Nano Today, 2012, 7(6): 514-531. *Authors contributed equally to this work.

  22. Nam SY, Ricles LM, Suggs LJ, and Emelianov SY. In vivo Ultrasound and Photoacoustic Monitoring of Mesenchymal Stem Cells Labeled with Gold Nanotracers. PLoS ONE, 2012, 7, e37267.

  23. Rytlewski JA, Geuss LR, Anyaeji CI, Lewis EW, and Suggs LJ. Three-Dimensional Image Quantification as a New Morphometry Method for Tissue Engineering. Tissue Engineering Part C: Methods. 2012 18(7): 507-516.

  24. Natesan S, Zamora DO, Suggs LJ, Christy RJ. Engineering a bilayered hydrogel to control ASC differentiation. J Vis Exp. 2012 May 25;(63):e3953.

  25. Hammers DW, Sarathy A, Pham CB, Drinnan CT, Farrar RP, Suggs LJ. Controlled release of IGF-I from a biodegradable matrix improves functional recovery of skeletal muscle from ischemia/reperfusion. Biotechnology and Bioengineering, 2012 April; 109(4): 1051–1059.

  26. Ricles LM, Nam SY, Sokolov K, Emelianov SY, and Suggs LJ. Function of mesenchymal stem cells following loading of gold nanotracers. Int J Nanomed 6: 407-416 (2011).

  27. Seidlits, S.K., C.T. Drinnan, R.R. Petersen, J.B. Shear, L.J. Suggs and C.E. Schmidt, “Fibronectin–hyaluronic acid composite hydrogels for three-dimensional endothelial cell culture,” Acta Biomater. 2011 June; 7(6): 2401-2409.

  28. Galler, K.M., A,C. Cavender, U. Koeklue, L. J. Suggs, G. Schmalz and R. N. D’Souza. Bioengineering of dental stem cells in a PEGylated fibrin gel. Regen Med. 2011 Mar; 6(2):191-200.

  29. Natesan, S., G. Zhang, D.G. Baer, T.J. Walters, R.J. Christy*, and L.J. Suggs*. A Bilayer Construct Controls Adipose Derived Stem Cell Differentiation into Endothelial Cells and Pericytes without Growth Factor Stimulation. Tissue Engineering, 2011 Apr; 17(7-8): 941-53. *authors contributed equally.

  30. Merritt, E.K., D. Hammers, M. Tierney, L.J. Suggs, T. Walters, and R.P. Farrar. Functional Assessment of Skeletal Muscle Regeneration Utilizing Homologous Extracellular Matrix as Scaffolding. Tissue Engineering, 2010, 16(4): p. 1395-1405; 2010.

  31. Merritt, E.K., M.V. Cannon, D.W. Hammers, L.N. Le, R. Gokhale, A. Sarathy, T.J. Song, M.T.Tierney, L.J. Suggs, T.J. Walters and R.P. Farrar. Repair of Traumatic Skeletal Muscle Injury with Bone marrow Derived Mesenchymal Stem Cells Seeded on Extracellular Matrix. Tissue Engineering, 16(9): p. 2871-2881; 2010.

  32. Drinnan CT, Zhang G, Alexander MA, Pulido AS, and Suggs LJ. Multimodal release of transformation growth factor-beta-1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels. Journal of Controlled Release (2010).

  33. Seetharaman S, Natesan S, Stowers RS, Mullens C, Baer DG, Suggs LJ, Christy RJ. A PEGylated Fibrin-Based Wound Dressing with Antimicrobial and Angiogenic Activity. Acta Biomaterialia (2010).

  34. Zhang G, Drinnan CT, Geuss LR, and Suggs LJ. Vascular differentiation of bone marrow stem cells is directed by a tunable three-dimensional matrix. Acta Biomaterialia (2010).

  35. Zhang G, Hu Q, Braunlin E, Suggs LJ, and Zhang J. Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin matrix. Tissue Engineering Part A. 2008 Jun;14(6):1025-36.

  36. Zhang JJ, King M, Suggs L, and Ren PY. Molecular modeling of conformational properties of oligodepsipeptides. Biomacromolecules. 2007 Oct;8(10):3015-24.

  37. Zhang G, Nakamura Y, Wang X, Hu Q, Suggs LJ, and Zhang J. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ homing to the infarcted heart. Tissue Engineering. 2007 Aug;13(8):2063-71.

  38. Zhang G and Suggs LJ. Matrices and scaffolds for drug delivery in vascular tissue engineering. Advanced Drug Delivery Reviews. 2007 May 30;59(4-5):360-73.

  39. Liu H, Collins SF, and Suggs LJ. Three-dimensional culture for expansion and differentiation of mouse embryonic stem cells. Biomaterials. 2006 Dec;27(36):6004-14.

  40. Zhang G, Wang Z, Wang X, Zhang J, and Suggs LJ. A PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Engineering. 2006 Jan;12(1):9-19.


Book chapters:

  1. Stowers RS and Suggs LJ. Micro and Nanotechnology for Vascular Tissue Engineering. In: Micro and Nanotechnologies in Engineering Stem Cells and Tissues. Ed. M Ramalingam et al. Wiley-IEEE, 2013.

  2. Drinnan CT, Geuss LR, Zhang G, and Suggs LJ. Tissue Engineering in Drug Delivery. In: Fundamentals and Applications of Controlled Release Drug Delivery. Rathbone MJ, editor. Part of series “Advances in Delivery Science and Technology.” Springer, 2012. pp. 533-568.

  3. Abdelmelek M, Nguyen M, Bradford V, Iverson B, and Suggs LJ. Synthesis of morpholine-2,5-dione monomers for the preparation of polydepsipeptides. ACS Symposium series: Biomaterials. 2010, vol. 1054, pp. 185-196.

  4. Suggs LJ, Moore SA, and Mikos AG. Synthetic biodegradable polymers for medical applications. In: Mark JE, editor. Physical properties of polymers handbook. 2nd ed. Woodbury: American Institute of Physics; 2007. p939-50.



Publications prior to UT Austin (<2004):


Peer-reviewed journal articles:

  1. S.J. Peter, L.J. Suggs, M.J. Yaszemski, P.S. Engel, and A.G. Mikos, “Synthesis of Poly(Propylene Fumarate) from an Acyl Chloride and a Diol in the Presence of a Carbonate Scavenger”, J. Biomater. Sci., Polym. Ed., 10, 363-373, 1999.

  2. L.J. Suggs, J.L. West, and A.G. Mikos, “Platelet Adhesion on a Bioresorbable Poly(Propylene Fumarate-co-Ethylene Glycol) Copolymer,” Biomaterials, 20, 683-690, 1999.

  3. L.J. Suggs, M.S. Shive, C.A. Garcia, J.M. Anderson, and A.G. Mikos, “In Vitro Cytotoxicity and In Vivo Biocompatibility of Poly(Propylene Fumarate-co-Ethylene Glycol) Hydrogels,” J. Biomed. Mater. Res., 46, 22-32, 1999.

  4. L.J. Suggs and A.G. Mikos, “Development of Poly(Propylene Fumarate-co-Ethylene Glycol) as an Injectable Carrier for Endothelial Cells,” Cell Transplantation, 8, 345-350, 1999.

  5. L.J. Suggs, E.Y. Kao, L.L. Palombo, R.S. Krishnan, M.S. Widmer, and A.G. Mikos, “Preparation and Characterization of Poly(Propylene Fumarate-co-Ethylene Glycol) Hydrogels,” J. Biomater. Sci., Polym. Ed., 9, 653-666, 1998.

  6. L.J. Suggs, R.S. Krishnan, C.A. Garcia, S.J. Peter, and A.G. Mikos, “In Vitro and In Vivo Degradation of Poly(Propylene Fumarate-co-Ethylene Glycol) Hydrogels,” J. Biomed. Mater. Res., 42, 312-320, 1998.

  7. L.J. Suggs, R.G. Payne, M.J. Yaszemski, L.B. Alemany, and A.G. Mikos, "Synthesis and Characterization of a Block Copolymer Consisting of Poly(Propylene Fumarate) and Poly(Ethylene Glycol)," Macromolecules, 30, 4318-4323, 1997.

  8. S.J. Peter, M.J. Yaszemski, L.J. Suggs, R.G. Payne, R. Langer, W.C. Hayes, M.R. Unroe, L.B. Alemany, P.S. Engel, and A.G. Mikos, "Characterization of Partially Saturated Poly(Propylene Fumarate) for Orthopaedic Application," J. Biomater. Sci., Polym. Ed., 8, 893-904, 1997.


Book chapters:

  1. L.J. Suggs and A.G. Mikos, "Synthetic Biodegradable Polymers for Medical Applications," in Physical Properties of Polymers Handbook, J.E. Mark, Ed., American Institute of Physics, Woodbury, 1996, pp. 615-624.

  2. L.J. Suggs, R.G. Payne, E.Y. Kao, L.B. Alemany, M.J. Yaszemski, K.K. Wu, and A.G. Mikos, "The Synthesis and Characterization of a Novel Block Copolymer Consisting of Poly(Propylene Fumarate) and Poly(Ethylene Oxide)," in Polymers in Medicine and Pharmacy, A.G. Mikos, K.W. Leong, M.J. Yaszemski, J.A. Tamada, and M.L. Radomsky, Eds., MRS Symposium Proceedings, Vol. 394, Materials Research Society, Pittsburgh, 1995, pp. 167-173.


HOME                                   RESEARCH AREAS                                    GROUP MEMBERS                                     PUBLICATIONS                                  CONTACT